CNS Pharmaceuticals Statistics
Total Valuation
CNSP has a market cap or net worth of $8.68 million. The enterprise value is -$11.30 million.
| Market Cap | 8.68M |
| Enterprise Value | -11.30M |
Important Dates
The last earnings date was Wednesday, August 12, 2026, before market open.
| Earnings Date | Aug 12, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
CNSP has 1.46 million shares outstanding. The number of shares has increased by 1,105.07% in one year.
| Current Share Class | 1.46M |
| Shares Outstanding | 1.46M |
| Shares Change (YoY) | +1,105.07% |
| Shares Change (QoQ) | +911.31% |
| Owned by Insiders (%) | 0.95% |
| Owned by Institutions (%) | 11.95% |
| Float | 1.31M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 0.47 |
| P/TBV Ratio | 0.47 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 5.86
| Current Ratio | 5.86 |
| Quick Ratio | 5.35 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -1,110.61 |
Financial Efficiency
Return on equity (ROE) is -106.62% and return on invested capital (ROIC) is -67.23%.
| Return on Equity (ROE) | -106.62% |
| Return on Assets (ROA) | -58.01% |
| Return on Invested Capital (ROIC) | -67.23% |
| Return on Capital Employed (ROCE) | -92.94% |
| Weighted Average Cost of Capital (WACC) | 9.64% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$2.09M |
| Employee Count | 8 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -8.33% in the last 52 weeks. The beta is 0.98, so CNSP's price volatility has been similar to the market average.
| Beta (5Y) | 0.98 |
| 52-Week Price Change | -8.33% |
| 50-Day Moving Average | 5.10 |
| 200-Day Moving Average | 4.88 |
| Relative Strength Index (RSI) | 58.74 |
| Average Volume (20 Days) | 7,477 |
Short Selling Information
The latest short interest is 11,374, so 0.78% of the outstanding shares have been sold short.
| Short Interest | 11,374 |
| Short Previous Month | 15,780 |
| Short % of Shares Out | 0.78% |
| Short % of Float | 0.87% |
| Short Ratio (days to cover) | 1.16 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -16.91M |
| Pretax Income | -16.70M |
| Net Income | -16.70M |
| EBITDA | -16.90M |
| EBIT | -16.91M |
| Earnings Per Share (EPS) | -$7.66 |
Balance Sheet
The company has $19.99 million in cash and no debt, with a net cash position of $19.99 million or $13.67 per share.
| Cash & Cash Equivalents | 19.99M |
| Total Debt | n/a |
| Net Cash | 19.99M |
| Net Cash Per Share | $13.67 |
| Equity (Book Value) | 18.20M |
| Book Value Per Share | 12.45 |
| Working Capital | 18.19M |
Cash Flow
In the last 12 months, operating cash flow was -$13.41 million and capital expenditures -$28,175, giving a free cash flow of -$13.44 million.
| Operating Cash Flow | -13.41M |
| Capital Expenditures | -28,175 |
| Depreciation & Amortization | 14,918 |
| Net Borrowing | -308,553 |
| Free Cash Flow | -13.44M |
| FCF Per Share | -$9.20 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
CNSP does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -1,105.07% |
| Shareholder Yield | -1,105.07% |
| Earnings Yield | -196.00% |
| FCF Yield | -157.76% |
Analyst Forecast
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (3Y) | n/a |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on July 22, 2025. It was a reverse split with a ratio of 1:12.
| Last Split Date | Jul 22, 2025 |
| Split Type | Reverse |
| Split Ratio | 1:12 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |